|Sep-Oct '03 | briefing | mail | don't say this | flakers' jargon | flaker creativity | articles | other places | archives | send mail | ed dewke | legal stuff | order | search | PsorChat | PsorChat Review | ©2001 Ed Dewke|
Out of Avandia Trial
Hi Ed, I wrote
to you ages ago — I was the grad student at Harvard working on telescope
design. I graduated this spring with my masters and am moving on in
September to start a PhD at the University of London, working on the
Euro50 telescope project.
I've been in
the clinical trial for Avandia since May, and am actually going to drop
out. I've seen no results, though I may be on placebo. The trial manager
told me only one person had seen any good results. They switch you between
placebo and the real thing at 6 months, but I just can't sit around
waiting to try a drug that might not work.
the study Dr., my psoriasis has now passed the 90% coverage mark. My nails
are hideous and I can barely move through the pain. I was thinking of
giving up my PhD spot, since I'm not sure I can manage. However, I have
new health insurance that has a 6 month pre-existing condition waiting
period. As soon as that 6 months is up, I'm going to try Amevive!
Hope you are
doing well — thanks for your website! -Christy
Response: Of course I remember
you, Christy. At the moment we
have only one Chair for astrophysics at FlakeHQ and you are the incumbent.
Doesn’t matter where you go for the doctorate, you occupy that
chair, here. (Rumor’s afoot
the chair will also be named after its first occupant.)
Sorry to hear
the Avandia trial didn’t work out for you.
You are my living witness to the potential cost of participating in
trials. I know they’re
necessary and if we didn’t have people volunteer for them we’d never
get anywhere with new drugs. But
when P is severe, as in your case, the conditions of participating in a
trial can be very costly.
who manage trials understand that if the subject becomes debilitated —
either because the trial drug doesn’t work or s/he’s receiving the
placebo — it cannot go on. If
they take this into consideration and account for some percentage of
drop-outs perhaps they can preserve the integrity of their data.
Sounds like you and I will be trying Amevive at about the same time. I’ll wish you well if you’ll wish me well! And I hope you don’t have to give up the PhD spot. You must fine some sun in London! -Ed